SG Americas Securities’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,320
| Closed | -$104K | – | 3741 |
|
|
2025
Q4 | $104K | Sell |
5,320
-3,949
| -43% | -$81.9K | ﹤0.01% | 3231 |
|
|
2025
Q3 | $255K | Buy |
+9,269
| New | +$285K | ﹤0.01% | 2597 |
|
|
2024
Q3 | – | Sell |
-7,522
| Closed | -$340K | – | 3611 |
|
|
2024
Q2 | $340K | Buy |
+7,522
| New | +$346K | ﹤0.01% | 1897 |
|
|
2023
Q4 | – | Sell |
-9,913
| Closed | -$581K | – | 3465 |
|
|
2023
Q3 | $581K | Buy |
+9,913
| New | +$620K | 0.01% | 1651 |
|
|
2023
Q2 | – | Sell |
-8,923
| Closed | -$561K | – | 3198 |
|
|
2023
Q1 | $561K | Sell |
8,923
-1,299
| -13% | -$77.5K | 0.01% | 1627 |
|
|
2022
Q4 | $544K | Buy |
10,222
+6,311
| +161% | +$342K | 0.01% | 1463 |
|
|
2022
Q3 | $219K | Sell |
3,911
-1,942
| -33% | -$128K | ﹤0.01% | 2245 |
|
|
2022
Q2 | $424K | Buy |
+5,853
| New | +$436K | ﹤0.01% | 2108 |
|
|
2022
Q1 | – | Sell |
-2,098
| Closed | -$212K | – | 3462 |
|
|
2021
Q4 | $212K | Sell |
2,098
-23,492
| -92% | -$2.34M | ﹤0.01% | 2643 |
|
|
2021
Q3 | $2.36M | Buy |
25,590
+24,102
| +1,620% | +$2.32M | 0.01% | 1118 |
|
|
2021
Q2 | $152K | Sell |
1,488
-377
| -20% | -$37.9K | ﹤0.01% | 2467 |
|
|
2021
Q1 | $182K | Sell |
1,865
-6,601
| -78% | -$601K | ﹤0.01% | 2734 |
|
|
2020
Q4 | $653K | Sell |
8,466
-12,140
| -59% | -$939K | ﹤0.01% | 1790 |
|
|
2020
Q3 | $1.52M | Buy |
20,606
+10,062
| +95% | +$807K | 0.01% | 935 |
|
|
2020
Q2 | $774K | Sell |
10,544
-4,849
| -32% | -$380K | 0.01% | 1665 |
|
|
2020
Q1 | $889K | Buy |
15,393
+8,416
| +121% | +$585K | 0.01% | 1379 |
|
|
2019
Q4 | $548K | Buy |
+6,977
| New | +$514K | 0.01% | 1697 |
|
|
2019
Q2 | – | Sell |
-2,297
| Closed | -$193K | – | 3442 |
|
|
2019
Q1 | $193K | Buy |
+2,297
| New | +$240K | ﹤0.01% | 2604 |
|
|
2018
Q4 | – | Sell |
-74,890
| Closed | -$9.03M | – | 3350 |
|
|
2018
Q3 | $9.03M | Buy |
74,890
+72,253
| +2,740% | +$8.97M | 0.07% | 299 |
|
|
2018
Q2 | $304K | Buy |
2,637
+1,047
| +66% | +$115K | ﹤0.01% | 2352 |
|
|
2018
Q1 | $137K | Buy |
+1,590
| New | +$123K | ﹤0.01% | 2710 |
|
|
2017
Q3 | – | Sell |
-2,520
| Closed | -$162K | – | 3742 |
|
|
2017
Q2 | $162K | Buy |
+2,520
| New | +$155K | ﹤0.01% | 2577 |
|
|
2017
Q1 | – | Sell |
-6,928
| Closed | -$424K | – | 3578 |
|
|
2016
Q4 | $424K | Sell |
6,928
-2,782
| -29% | -$181K | ﹤0.01% | 1808 |
|
|
2016
Q3 | $672K | Sell |
9,710
-19,324
| -67% | -$1.27M | 0.01% | 1468 |
|
|
2016
Q2 | $1.62M | Buy |
+29,034
| New | +$1.75M | 0.01% | 981 |
|
|
2015
Q4 | – | Sell |
-3,222
| Closed | -$216K | – | 3000 |
|
|
2015
Q3 | $216K | Buy |
+3,222
| New | +$228K | ﹤0.01% | 1410 |
|
|
2014
Q1 | – | Sell |
-2,664
| Closed | -$101K | – | 2794 |
|
|
2013
Q4 | $101K | Sell |
2,664
-620
| -19% | -$23.7K | ﹤0.01% | 2404 |
|
|
2013
Q3 | $143K | Buy |
+3,284
| New | +$132K | ﹤0.01% | 2418 |
|
Other funds holding USNA
NCM
VCM
VPM
SG Americas Securities's USNA Position: Q1 2026 in Review
SG Americas Securities sold out of Usana Health Sciences (USNA) in Q1 2026, closing a stake of 5,320 shares — an estimated $104K sold.
SG Americas Securities first reported a position in USNA in Q3 2013 and held it in 28 quarters. The position peaked at $9.03M in Q3 2018. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.
- SG Americas Securities reported no remaining Usana Health Sciences position as of Q1 2026 after selling out during the quarter.
- SG Americas Securities sold 5,320 Usana Health Sciences shares in Q1 2026, an estimated $104K.
- SG Americas Securities first reported a position in Usana Health Sciences in Q3 2013 and held it in 28 quarters.
- SG Americas Securities's Usana Health Sciences position peaked at $9.03M in Q3 2018.
- 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.